Effect of growth hormone on bone density and body composition in Chinese patients with transitional growth hormone deficiency.

What Was Tested

This observational study looks at Exogenous HGH, sermorelin & older GHRPs (why they're passed over).

This study evaluated the effects of recombinant human growth hormone (rhGH) on bone mineral density (BMD) and body composition in Chinese adolescents with transitional growth hormone deficiency (TGHD).

A prospective cohort study was conducted from September 2021 to September 2024, involving 37 TGHD patients (15-18 years) and 7 healthy controls.

Who Took Part

The study group was 37 patients.

PubMed indexes the participants as teenagers, both men and women.

What Was Measured

This study evaluated the effects of recombinant human growth hormone (rhGH) on bone mineral density (BMD) and body composition in Chinese adolescents with transitional growth hormone deficiency (TGHD).

Assessments included dual-energy X-ray absorptiometry (DXA) for BMD and body composition, biochemical profiling, grip strength, and cardiac ultrasound.

Topics PubMed links to this paper include Bone Density, Body Composition, Human Growth Hormone, China, Absorptiometry, Photon, Hand Strength and East Asian People.

Author keywords: bone mineral density, metabolic outcomes, recombinant human growth hormone and transitional growth hormone deficiency.

What This Means in Plain Language

This is an observational study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in 37 patients.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

The publication is from 2025 (Medicine), a journal based in United States.

More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.